Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 4/5/2025CASI Pharma Evaluates CEO's $40M Proposal for China Operations
  • 4/5/2025Global Pharma Leaders Engage with President Xi Amidst U.S.-China Trade...
  • 4/5/2025China and WHO Collaborate on Quality Management Training to Boost Vacc...
  • 4/5/2025Novartis' Fabhalta (iptacopan) Approved in China for C3 Glomerulopathy
  • 4/5/2025Sanofi and Cathay Capital Launch CNY 2B Healthcare Innovation Fund in ...
  • 4/5/2025Hansoh Initiates Phase 1 Trial for ADC Drug HS-20122 Targeting Advance...
  • 4/5/2025BeiGene Terminates Development of Ociperlimab Following Unfavorable Tr...
  • 4/1/2025Biotheus Initiates Phase 3 Trial for BNT327/PM8002 in China
  • 4/1/2025Vivace Thera Raises $35M in Series D Financing
  • 4/1/2025Akeso Eyes U.S. Approval for Innovative Lung Cancer Therapy
  • 4/1/2025China Accelerates Brain Chip Trials After Initial Success
  • 3/31/2025Merck KGaA Acquires Commercialization Rights to Abbisko's Pimicotinib
  • 3/31/2025Bio-Thera and Dr. Reddy's Execute Commercialization Deal for BAT2206 a...
  • 3/31/2025Roche's Ocrevus Receives Chinese Approval for MS
  • 3/31/2025Hengrui Medicine Expands Phase 3 Trials for Oral GLP-1R Agonist HRS-75...
  • 3/31/2025BMS's Opdivo and Yervoy Combio Approved in China
  • 3/31/2025Vcare PharmaTech Secures Series C+ Financing and Advances Clinical Pip...
  • 3/31/2025CDE Solicits Comments on the Draft Technical Specification of ICH M11:...
  • 3/28/2025Recent Executive Moves
  • 3/28/2025TaiMed Announces Results from Phase 2a Data on Long-Acting HIV Mainten...
  • 3/28/2025NiKang Thera Completes Dosing of the First Cohort in a Phase 1 Study ...
  • 3/28/2025AstraZeneca Advances AZD0120 CAR-T Trial for Lupus
  • 3/28/2025Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Pa...
  • 3/28/2025GenFleet Thera Reports Promising Phase II Results for Fulzerasib and C...
  • 3/28/2025Chinese Scientists Develop Breakthrough Vaccine Molecule to Enhance Im...
  • 3/28/2025DualityBio Advances Toward Hong Kong Stock Exchange Listing
  • 3/28/2025Eisai to Divest China Rights for Pariet® to Peak Pharma
  • 3/27/2025NMPA Approves Suraxavir Marboxil for Influenza Treatment
  • 3/27/2025China Faces Ongoing TB Prevention Challenges Despite Declining Inciden...
  • 3/27/2025China Poised to Surpass Europe in Pharma Innovation, Says AZ CEO
  • Page:3/47 Total number of articles:1391: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group